Please login to the form below

Not currently logged in
Email:
Password:

Bo Jesper Hansen to step down as chairman of Sobi

Håkan Björklund will be nominated as his replacement

Sobi's Bo Jesper Hansen is to step down as chairman of the board, a role he has held since the merger of Biovitrum and Swedish Orphan International in 2010.

Hansen joined Swedish Orphan International AB in 1993 and served as its chief executive officer between 1998 and 2010. He has also been a medical advisor to Pfizer, Pharmacia and Yanaouchi and founded Scandinavian Medical Research.

In a statement, Sobi credited Hansen with growing the specialty healthcare company into an “international pioneer in rare diseases with a strong commercial footprint across Europe, North America, the Middle East and Russia”.

Hansen's proposed replacement is Håkan Björklund, who currently serves as private equity firm Avista Capital Partners' healthcare industry executive.

Björklund served as chief executive officer at Nycomed until 2011 and oversaw its growth from a largely Scandinavian business into a global pharmaceutical company operating across Europe, Latin America and Russia.

He has also served as a member of several firms' board of directors, including Alere, Coloplast, Danisco, Lundbeck and Biovitrum.

Björklund's appointment as chairman will be announced after the company's annual shareholder meeting later this year.

2nd March 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...
Understanding the evolving CAR-T market
In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in...

Infographics